Location: Home
  • search
  • go
  • Relate News
  • 11/28/2022Biocytogen Enters into Antibody Agreement with ADC Therapeutics
  • 11/28/2022Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Pep...
  • 11/28/2022India's API import from China May Fall 25% in the Next Five Years
  • 11/28/2022China Is to Begin Formal Access Negotiation for the 2022 NRDL
  • 11/28/2022Overview of China Drug Review Annual Report (2015-2021)
  • 11/28/2022What Does Biden's Directive on Foreign Biotech Investments Mean for Ma...
  • 11/26/2022CAR-T Therapies See New Competitors Emerge in October (PharmaDJ)
  • 11/25/2022CDE Issues the Technical Guidelines for Bioequivalence Study of Four D...
  • 11/25/2022Drug R&D and Product Registration News Digest November 2022 (4)
  • 11/25/2022Recent Executive Moves
  • 11/25/2022CK Life Sciences Teams Up with XtalPi to Develop Cancer Vaccines
  • 11/24/2022Fosun's Wanbang and Sirona Biochem Sign New Licensing Pact For Non-Ins...
  • 11/24/2022BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requir...
  • 11/24/2022China Issues the National Action Plan for Containment of Microbiologic...
  • 11/24/2022CDE Issues the Guidelines for General Considerations in Organizing Pat...
  • 11/24/2022CDE Solicits Comments on the Technical Guidelines for Clinical Researc...
  • 11/24/2022IQVIA: Chinese Hospital Drug Market Steady in MAT Q3/2022
  • 11/24/2022Chinese Pharma Companies Won 63 U.S. ANDAs in the First Ten Months of ...
  • 11/24/2022Drug R&D and Approvals in China – October Update on YouTube (PharmCub...
  • 11/23/2022Shanghai Issues the "Certain Policy Measures to Accelerate Building of...
  • 11/23/2022Fibrogen Sues Andao / Kind Pharma and Two Ex-employees for Stolen Pate...
  • 11/23/2022Jinyao Pharma Fined CNY 27.72M for Additional Monopoly Violation
  • 11/23/2022WuXi AppTec Begins Construction of Wuxi STA's East China R&D Facility
  • 11/23/2022GlobalData: Chinese Manufacturers' Transition to Innovative Pharma Req...
  • 11/23/2022China to Cut Tax for More Anticancer and Rare Disease Drugs
  • 11/23/2022NMPA and Chinese Customs Announce Addition of Shijiazhuang Airport as ...
  • 11/23/2022Hainan Issues New Policy to Improve Drug Import Process
  • 11/23/2022Nona Biosciences Enters into HCAb Based Drug Discovery Partnership wit...
  • 11/23/2022Umoja Biopharma and IASO Biotherapeutics Enter Partership for Off-the-...
  • 11/22/2022Measures for Supervision and Administration of Online Sales of Drugs: ...
  • Page:143/798 Total number of articles:23912: [First][<<] [141] [142] [143] [144] [145] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group